News Results
There are 77,405 News Results
Dec 5, 2017
LYON, France, December 6, 2017 /PRNewswire/ -- Novasep, a leading supplier of services and technologies for the life sciences industry, announces a EUR17M investment in a dedicated GMP mAb production...
Dec 5, 2017
PHILADELPHIA, Dec. 6, 2017 /PRNewswire-USNewswire/ --
Dec 6, 2017
DUBLIN, Dec. 7, 2017 /PRNewswire/ -- The "Global Ophthalmology Drugs Market to 2023 - Angiogenesis Inhibitors in wAMD Set to Retain High Market Share, While Expansive Pipeline for Glaucoma Leads...
Dec 6, 2017
NEW YORK, December 7, 2017 /PRNewswire/ -- Merger and acquisition (M&A) activity in the cannabis industry is heating up, and market analysts point to several important factors contributing to increased...
Dec 6, 2017
NEW YORK, December 7, 2017 /PRNewswire/ -- Merger and acquisition (M&A) activity in the cannabis industry is heating up, and market analysts point to several important factors contributing to increased...
Dec 6, 2017
DUBLIN, Dec. 7, 2017 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the company will be webcasting its corporate presentation at the BMO Capital Markets Healthcare Conference in...
Dec 10, 2017
ALBANY, New York, December 11, 2017 /PRNewswire/ -- Presence of several enterprises has rendered the global anti-venom market highly fragmented. In a new study, Transparency Market Research (TMR) identifies companies...
Dec 10, 2017
NEW YORK, December 11, 2017 /PRNewswire/ -- MarketResearch.biz announces publication of its most recently generated research report titled, "Global Biosimilar Monoclonal Antibodies Market [ https://marketresearch.biz/report/biosimilar-monoclonal-antibodies-market ] by Drug Class (Rituximab,...
Dec 10, 2017
OXFORD, Miss., Dec. 11, 2017 /PRNewswire/ -- Cloaked Therapeutics and Romulus Titan have formed a joint venture, Cloaked Therapeutics Development, LLC, to facilitate development of the TumorSelect(®) cancer chemotherapy platform....
Dec 10, 2017
TOKYO, Dec. 11, 2017 /PRNewswire/ -- Astellas Pharma Inc. (TSE: 4503, President and CEO: Yoshihiko Hatanaka, "Astellas") announced today the first reported data of the investigational agent gilteritinib from the...